Australian Pharma Under Pressure to Provide Full Documentation for GMP Clearance

Executive Summary Pharma firms in Australia have been told to up their game when applying for GMP clearance of overseas manufacturing plants. The Therapeutic Goods Administration says too many applications don’t contain all the necessary documentation, and from Sept. 26 new processes will be introduced putting more of the onus on sponsors.

Executive Summary

Pharma firms in Australia have been told to up their game when applying for GMP clearance of overseas manufacturing plants. The Therapeutic Goods Administration says too many applications don’t contain all the necessary documentation, and from Sept. 26 new processes will be introduced putting more of the onus on sponsors.

Source: pink.pharmamedtechbi.com